Licochalcone A ameliorates lipid accumulation in metabolic dysfunction-associated steatotic liver disease via upregulating PPARα/CPT1α.
This study demonstrated that LiA ameliorates the lipid metabolism disorder in MASLD mice by upregulating the PPARα/CPT1α signaling pathway.
Authors
- Rui Yan (ORCID: https://orcid.org/0000-0003-4496-9940)
- Yantao Zhu (ORCID: https://orcid.org/0000-0003-4085-3246)
- Guojun Wang (ORCID: https://orcid.org/0000-0002-2945-3033)
- Wenrui Zhu
- Hongfeng Xu
- L. Qiu (ORCID: https://orcid.org/0000-0002-1263-5420)
Institutions
- Zhejiang Chinese Medical University (CN)
- Jinhua Academy of Agricultural Sciences (CN)
- The Third Affiliated Hospital of Zhejiang Chinese Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-12-01
- DOI
- https://doi.org/10.14670/hh-18-907
- Citations
- 1
- Primary Topic
- Pharmacological Effects of Natural Compounds
- Type
- article
- Field-Weighted Citation Impact
- 1.56